Mercy Pesa Okania
@pesaokania
ID: 911176348676354048
22-09-2017 10:32:25
676 Tweet
50 Takipรงi
340 Takip Edilen
๐Join us for "Until We Are All Equal: Imagining Equal Power" on 4 Sep at 9 am PDT. Solange Baptiste as well as Assistant Secretary Loyce Pace & Rajat Khosla will talk global health power dynamics & new models for equitable governance. RSVP here: tinyurl.com/iigh-imaginingโฆ USC Institute on Inequalities in Global Health
Read about collaborative dialogues convened by KELIN with support from Aidsfonds International focusing on HIV prevention tools and IP challenges affected access to medicines. Mercy Pesa Okania Read prevention study findings here: kelinkenya.org/wp-content/uplโฆ kelinkenya.org/collaborative-โฆ
Today, KELIN with support from ITPC Global Make Meds Affordable is hosting national stakeholders to validate findings of a market intelligence study conducted in Kenya. Study collected data on costs and delivery, pricing and procurement practices of HIV & TB products in Kenya.
One finding of the #marketintelligence study is that KEMSA is largely price-efficient in key ARVs - hence the need to ensure proper management at #KEMSA to ensure #KEMSA works for access to medicines to all. KELIN Make Meds Affordable ITPC Global
KEMSA KELIN Make Meds Affordable ITPC Global UNITAID NGOs Unitaid Health NGOs Network (HENNET) World Health Organization (WHO) Mercy Pesa Okania Patricia Asero The Global Fund PEPFAR Pharmacy and Poisons Concern flagged by #marketintelligence study is access to 3rd line adult & Paediatric ARVs. These were flagged as most difficult to source with highest prices & few people on them. #Accesstomedicines for all means ensuring even limited use drugs are prioritized. KELIN
KEMSA KELIN Make Meds Affordable ITPC Global UNITAID NGOs Unitaid Health NGOs Network (HENNET) World Health Organization (WHO) Mercy Pesa Okania Patricia Asero The Global Fund PEPFAR Pharmacy and Poisons Solange Baptiste Unitaid Communities USAID Kenya Ministry of Health The #marketintelligence study establishes that sourcing TB medicines in Kenya is characterized by extremely long lead times which often result in stock-outs. Study also finds that more work is needed to expand access in TB, cancer & Hep C treatment. Network of TB Champions Kenya
LIVE from Kampala! KELIN validating the MPI Study for Uganda! Partnering with CEHURD Uganda & backed by ITPC Global, pushing boundaries to ensuring better access to life saving drugs. Shaping the future of health equity! #AccessForAll #HealthJustice Wanameme KELIN
โThe ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐๐ป๐๐ฒ๐น๐น๐ถ๐ด๐ฒ๐ป๐ฐ๐ฒ ๐ฆ๐๐๐ฑ๐ provides valuable insights into the epidemiology, legal environment, and procurement landscape for priority health products targeting HIV, TB, HCV, Hepatitis, cervical cancer interventions and how that affects access to
Happening now at the Afya na Haki offices a partners conversation on advancing collaborations between ๐บ๐ฌand ๐ฐ๐ชin litigating reproductive justice in Africa Owomugisha Bazare Immaculate CEHURD Uganda UNFPA KELIN #reproductiverights #Justice2health